Omnicide is a long-lasting, non-antibiotic, petrolatum based topical gel with proven effectiveness against even the most resistant, virulent bacteria, such as Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus, and Carbapenem-resistant Enterobacteriaceae.
According to SteriWeb Medical, laboratory data has also showed complete effectiveness against pathogenic fungi, molds, and yeasts, rendering Omnicide an appropriate choice for a wide variety of clinical conditions and an ideal addition to any topical infection treatment protocol.
SteriWeb Medical claims that Omnicide’s unique combination of antimicrobial ingredients differentiates it from topical antibiotics, which have become far less clinically effective as pathogenic bacteria, such as MRSA, have developed, and continue to develop, resistance over time.
SteriWeb Medical founder and COO Bradley Burnam said that in light of the recent World Health Organization’s landmark report on antibiotic resistance, it is clear that currently available topical infection treatments are becoming less and less effective.
"Omnicide is a timely and important innovation," Burnam added.
